Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer–treated rats

Min-Kaung-Wint-Mon, Hiroyuki Kida, Ryoichi Kimura, Dai Mitsushima · 2026

Read Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer–treated rats by Min-Kaung-Wint-Mon, Hiroyuki Kida, Ryoichi Kimura, Dai Mitsushima (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615615.txt.

Description

Min-Kaung-Wint-Mon and three co-authors test the drug riluzole against amyloid-driven memory loss in rats, in a study from twenty twenty-six. Sticky amyloid oligomers poison synapses, stir the brain's support cells, and impair memory in Alzheimer's disease. Riluzole, approved for Lou Gehrig's disease, calms overexcited neurons.

Amyloid was injected into the rats' memory hub, followed by a week of daily drug. Treated rats learned contexts and worked spatial memory better, with movement, anxiety, and pain responses unchanged. The drug cut neuronal amyloid buildup, and that cut tracked each animal's learning gains. Support cells swallowed and digested more amyloid, shifting toward a protective state. Neuron death, branch decay, spine loss, and complement-driven synapse removal all eased.

Catalog record

CREATORMin-Kaung-Wint-Mon, Hiroyuki Kida, Ryoichi Kimura, Dai Mitsushima
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13615615

Browse the full library · About the Tower of Babel